The Anglo-Swedish pharmaceutical giant said Tuesday that for the second quarter, core earnings per share rose to $2.17 from $1.98 in the same period a year prior. Revenue increased to $14.46 billion ...

(Alliance News) - AstraZeneca PLC on Tuesday reported better-than-expected second quarter revenue, and raised its dividend, boosted by strong sales from its cancer portfolio.

(Alliance News) - AstraZeneca raised its dividend as drug growth pushed earnings higher, Barclays launched a new buyback programme after profit jumped while Greggs saw profit fall despite higher sales ...

AstraZeneca PLC (NASDAQ: AZN) ranks among the stocks to benefit from an onshoring boom. AstraZeneca PLC (NASDAQ:AZN) ...

Democrats assert in the court case that the vote of a Senate committee rejecting the appointees means they cannot serve. A ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

Princess Charlotte, 10, Makes Surprise Appearance with Prince William at Her First Overseas Soccer Game 'Married... With Children' stars expose behind-the-scenes drama of beloved sitcom The 2028 ...

AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.

Governor Glenn Youngkin spoke with 8News about AstraZeneca’s recent announcement to build their world’s-largest manufacturing ...

The deal, which Youngkin signed on Monday, has not been reviewed by the Democrat-controlled General Assembly. The governor ...

The pharma sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused medicines it sells ...

Sen. Tim Kaine has been involved with bringing pharmaceutical reseach and development to central Virginia since his days on ...